89 related articles for article (PubMed ID: 36403042)
1. Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity.
Dai W; Zhong A; Qiao Q; Wu J; Li W; Wu Q; Zhou H; Qin S; Jiang W; Zhang J; Xia X
Virol J; 2022 Nov; 19(1):192. PubMed ID: 36403042
[TBL] [Abstract][Full Text] [Related]
2. Alterations in B and NK cells highly correlate with disease severity in children with COVID-19.
Topyildiz E; Edeer Karaca N; Taşkin B; Aygün A; Şahbudak Bal Z; Saz EU; Kurugöl NZ; Kütükçüler N; Aksu G
Turk J Med Sci; 2023; 53(5):1205-1213. PubMed ID: 38813014
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of lymphocyte subpopulations in the peripheral blood of patients with COVID-19: Implications for disease severity and prognosis.
Xu X; Huang J; Zhang H; Lu W; Liu J
Immun Inflamm Dis; 2024 May; 12(5):e1281. PubMed ID: 38780019
[TBL] [Abstract][Full Text] [Related]
4. Analysis of peripheral lymphocyte subsets and T-cell exhaustion in SARS-CoV-2 Infection.
Soyyiğit Ş; Öksüzer Çimşir D; Öncül A; Pekel A; Öner Erkekol F; Güner R; İzdeş S; Gökmen D; Gökbulut Bektaş Ş; İnan O; Gemcioğlu E; Yılmaz A; Şahiner ES; Hasanoğlu İ; Kaya Kalem A; Kayaaslan B; Eser F; Ateş İ
Tuberk Toraks; 2024 Jun; 72(2):152-166. PubMed ID: 38869208
[TBL] [Abstract][Full Text] [Related]
5. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19.
Bergantini L; d'Alessandro M; Cameli P; Cavallaro D; Gangi S; Cekorja B; Sestini P; Bargagli E
Cells; 2021 Nov; 10(11):. PubMed ID: 34831404
[TBL] [Abstract][Full Text] [Related]
6. T-cell responses in COVID-19 survivors 6-8 months after infection: A longitudinal cohort study in Pune.
Suryawanshi P; Patil-Takbhate B; Athavale P; Mirza S; Tripathy A; Kanitkar S; Shivnitwar S; Barthwal MS; Dole S; Chavan H; Jali P; Pawale S; Kakad D; Kakrani AL; Bhawalkar J; Gandhi M; Chaturvedi S; Karandikar M; Tripathy S
Immun Inflamm Dis; 2024 Jun; 12(6):e1238. PubMed ID: 38860770
[TBL] [Abstract][Full Text] [Related]
7. Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019.
Meng L; Xu J; Zhang J; Zhang K; Shang P; Li Q; Li Y; Wang L; Cai B
Aging (Albany NY); 2021 Mar; 13(6):7723-7732. PubMed ID: 33741750
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of lymphocyte subsets and inflammatory factors in patients with COVID-19.
Chen Z; Li J; Zheng J; Xiang F; Li X; Zhang M; Kang X; Wu R
Heliyon; 2024 Mar; 10(6):e28451. PubMed ID: 38545136
[TBL] [Abstract][Full Text] [Related]
9. Early immune responses and prognostic factors in children with COVID-19: a single-center retrospective analysis.
Lu W; Yang L; Li X; Sun M; Zhang A; Qi S; Chen Z; Zhang L; Li J; Xiong H
BMC Pediatr; 2021 Apr; 21(1):181. PubMed ID: 33865340
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.
Jiang N; Li Z; Yang B; Jin M; Sun Y; He Y; Liu Y; Wang Y; Si D; Ma P; Zhang J; Liu T; Yu Q
Biomed Res Int; 2021; 2021():9101082. PubMed ID: 33542929
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.
Kalicińska E; Szymczak D; Zińczuk A; Adamik B; Smiechowicz J; Skalec T; Nowicka-Suszko D; Biernat M; Bogucka-Fedorczuk A; Rybka J; Martuszewski A; Gozdzik W; Simon K; Wróbel T
Cells; 2021 May; 10(6):. PubMed ID: 34071149
[TBL] [Abstract][Full Text] [Related]
12. Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity.
Tu TH; Grunbaum A; Santinon F; Kazanova A; Rozza N; Kremer R; Mihalcioiu C; Rudd CE
Commun Biol; 2024 May; 7(1):526. PubMed ID: 38702425
[TBL] [Abstract][Full Text] [Related]
13. The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.
Saito S; Bozorgmehr N; Sligl W; Osman M; Elahi S
J Immunol; 2024 May; 212(10):1540-1552. PubMed ID: 38517295
[TBL] [Abstract][Full Text] [Related]
14. T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVID.
Cezar R; Kundura L; André S; Lozano C; Vincent T; Muller L; Lefrant JY; Roger C; Claret PG; Duvnjak S; Loubet P; Sotto A; Tran TA; Estaquier J; Corbeau P
Front Immunol; 2023; 14():1335352. PubMed ID: 38235145
[TBL] [Abstract][Full Text] [Related]
15. Differential dynamics of peripheral immune responses to acute SARS-CoV-2 infection in older adults.
Lewis SA; Sureshchandra S; Zulu MZ; Doratt B; Jankeel A; Ibraim IC; Pinski AN; Rhoades NS; Curtis M; Jiang X; Tifrea D; Zaldivar F; Shen W; Edwards RA; Chow D; Cooper D; Amin A; Messaoudi I
Nat Aging; 2021 Nov; 1(11):1038-1052. PubMed ID: 37118336
[TBL] [Abstract][Full Text] [Related]
16. A generalizable and easy-to-use COVID-19 stratification model for the next pandemic via immune-phenotyping and machine learning.
He X; Cui X; Zhao Z; Wu R; Zhang Q; Xue L; Zhang H; Ge Q; Leng Y
Front Immunol; 2024; 15():1372539. PubMed ID: 38601145
[TBL] [Abstract][Full Text] [Related]
17. Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months.
Santopaolo M; Gregorova M; Hamilton F; Arnold D; Long A; Lacey A; Oliver E; Halliday A; Baum H; Hamilton K; Milligan R; Pearce O; Knezevic L; Morales Aza B; Milne A; Milodowski E; Jones E; Lazarus R; Goenka A; Finn A; Maskell N; Davidson AD; Gillespie K; Wooldridge L; Rivino L
Elife; 2023 Jun; 12():. PubMed ID: 37310006
[TBL] [Abstract][Full Text] [Related]
18. CD4
Eryılmaz-Eren E; Köker MY; Ulu-Kılıç A; Hürmet-Öz HT; Ay-Altıntop Y; Saatçi E; Özsoy S; Kılınç-Toker A; Topaloğlu US; Yüksel RC; Avcılar H; Beştepe-Dursun Z; Çelik İ
Infect Dis Clin Microbiol; 2023 Mar; 5(1):23-30. PubMed ID: 38633909
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study.
Zhao B; Zhong M; Yang Q; Hong K; Xia J; Li X; Liu Y; Chen YQ; Yang J; Huang C; Yan H
Virol Sin; 2021 Oct; 36(5):859-868. PubMed ID: 33560482
[TBL] [Abstract][Full Text] [Related]
20. HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients.
Greco S; Made' A; Mutoli M; Zhang L; Piella SN; Vausort M; Lumley AI; Beltrami AP; Srivastava PK; Milani V; Boveri S; Ranucci M; Renna LV; Firat H; Bruno A; Spinetti G; Emanueli C; Devaux Y; Martelli F
J Transl Med; 2023 Oct; 21(1):758. PubMed ID: 37884975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
